Clinical Trials
3 trialsNCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04682587 2025-01-03
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Pfizer
Completed
NCT02791594 2024-11-08
Imaging FDG Flare in Melanoma
Abramson Cancer Center at Penn Medicine
Completed